These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1100015)

  • 1. The leukocyte aggregation test: immunodiagnostic applications and immunotherapeutic implications for clinical renal transplantation.
    Kahan BD; Krumlovsky F; Ivanovitch P; Greenwald J; Firlit C; Bergan J; Tom BH
    Arch Surg; 1975 Aug; 110(8):984-90. PubMed ID: 1100015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunodiagnostic test for transplant rejection.
    Kahan BD; Tom BH; Mittal KK; Bergan JJ
    Lancet; 1974 Jan; 1(7846):37-42. PubMed ID: 4128833
    [No Abstract]   [Full Text] [Related]  

  • 3. Characteristics of the leucocyte-aggregation assay for cell-mediated immunity.
    Tom BH; Huang LO; Jakstys MM; Kahan BD
    Clin Exp Immunol; 1975 Apr; 20(1):131-41. PubMed ID: 54234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunological diagnosis of the kidney allograft rejection reaction].
    Drannik GN
    Urol Nefrol (Mosk); 1981; (5):64-71. PubMed ID: 6458144
    [No Abstract]   [Full Text] [Related]  

  • 5. [The migration activity of blood leukocytes as an index of the immunologic status of a kidney allograft recipient].
    Shabanova LN; Artemova AG; Sofronov BN
    Urol Nefrol (Mosk); 1989; (3):53-7. PubMed ID: 2672530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of high doses of glucocorticoids on T-cell subsets in renal transplantation.
    Minetti L; Brando B; Civati G; Rovati C
    Adv Exp Med Biol; 1984; 171():345-51. PubMed ID: 6232834
    [No Abstract]   [Full Text] [Related]  

  • 7. Cell migration studies in human renal allograft recipients.
    Skopińska E; Gradowska L; Wojtulewicz-Kurkus J; Lao M; Wasik M; Rowińska D; Orłowski T
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):981-6. PubMed ID: 373696
    [No Abstract]   [Full Text] [Related]  

  • 8. The transmission of donor-derived malignant melanoma to a renal allograft recipient.
    Milton CA; Barbara J; Cooper J; Rao M; Russell C; Russ G
    Clin Transplant; 2006; 20(5):547-50. PubMed ID: 16968479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New approaches to immunosuppression in renal transplantation.
    Stuart FP
    Urol Clin North Am; 1976 Oct; 3(3):575-96. PubMed ID: 790732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-vitro leucocyte migration in renal transplantation.
    Green MK; Clunie GJ
    Med J Aust; 1974 May; 1(19):740-4. PubMed ID: 4602102
    [No Abstract]   [Full Text] [Related]  

  • 11. Renal donor pretreatment with cytotoxic agents: immunologically ineffective and damaging to the graft.
    Burleson RL; Jones DB; Yenikomshian A; DeVoe C; DeRito J
    Transplant Proc; 1977 Sep; 9(3):1591-6. PubMed ID: 331594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The early diagnosis of rejection by the leucocyte migration test in cadaveric renal transplantation.
    Williams RJ; Mallick NP; Taylor G; Orr WM
    Clin Nephrol; 1974; 2(3):100-5. PubMed ID: 4137252
    [No Abstract]   [Full Text] [Related]  

  • 13. Thymoglobulin-Resistant T-Cell-Mediated Acute Rejection in a Pregnant Renal Transplant Recipient: Case Report and Review of the Literature.
    Balaha M; Al-Otaibi T; Gheith OA; Halim MA; Shaker M; Fayyad Z; Nair P; Zakaria Z; Abo-Atya H; Makkeyia Y
    Exp Clin Transplant; 2019 Jan; 17(Suppl 1):159-163. PubMed ID: 30777545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of peripheral blood leukocyte activity following canine renal allotransplantation.
    Pauly JL; Varkarakis MJ; Germain MJ; Murphy GP
    J Med; 1974; 5(5):221-8. PubMed ID: 4606248
    [No Abstract]   [Full Text] [Related]  

  • 15. [The use of high doses of soluble Urbason in the treatment of renal transplants].
    Cucchiara G; Alfani D; Antonacci V; Berloco P; Famulari A; Sturniolo A; Rizzo F
    Minerva Med; 1980 Feb; 71(4):269-72. PubMed ID: 6986588
    [No Abstract]   [Full Text] [Related]  

  • 16. Transfer factor, homograft rejection and the effects of antilymphocyte serum in man.
    Lawrence HS
    Fed Proc; 1970; 29(1):183-5. PubMed ID: 4904622
    [No Abstract]   [Full Text] [Related]  

  • 17. [Improvement of the results of renal transplantation by the use of antilymphocyte globulin (ALG)].
    Renna E; Alfani D; Monari C; Trovati A; Berloco P; Famulari A; Cucchiara G; Cortesini R
    Minerva Chir; 1980 May; 35(10):747-50. PubMed ID: 7005730
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical value of the rosette inhibition test in renal allotransplantation.
    Cantaluppi A; Tarantino A; Donati D; Ponticelli C
    Transplant Proc; 1979 Mar; 11(1):379-81. PubMed ID: 377660
    [No Abstract]   [Full Text] [Related]  

  • 19. Alloantibodies and outcomes of deceased donor kidney allografts.
    Cinti P; Pretagostini R; Lai Q; Tamburro ML; Rossi M; Poli L; Berloco P
    Hum Immunol; 2009 Aug; 70(8):651-4. PubMed ID: 19527761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of antibody mediated rejection shortly after acute cellular rejection in a pediatric kidney transplantation recipient.
    Okada M; Kamei K; Matsuoka K; Ito S
    CEN Case Rep; 2018 Nov; 7(2):288-291. PubMed ID: 29949115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.